Hepatitis B vaccine effectiveness in the face of global HBV genotype diversity. - Wikidata - wikimedia - TriplyDB

Hepatitis B vaccine effectiveness in the face of global HBV genotype diversity.

Hepatitis B vaccine effectiveness in the face of global HBV genotype diversity.

http://www.wikidata.org/entity/Q37956379

about

Better plans and more powerful evidence are needed in the research and treatment of chronic hepatitis B in China.Chronic viral hepatitis: policy, regulation, and strategies for its control and elimination in Ethiopia Molecular epidemiology and genotyping of hepatitis B virus of HBsAg-positive patients in Oman.Molecular identification of hepatitis B virus genotypes/subgenotypes: revised classification hurdles and updated resolutions.Validation of cross-genotype neutralization by hepatitis B virus-specific monoclonal antibodies by in vitro and in vivo infection.Hepatitis B viral replication influences the expression of natural killer cell ligands.Immunization of Mice by BCG Formulated HCV Core Protein Elicited Higher Th1-Oriented Responses Compared to Pluronic-F127 Copolymer.Non-antigen-specific and antigen-specific immune therapies for chronic hepatitis B: evidences from laboratory benches and patient's bedsides.Improving clinical outcomes of chronic hepatitis B virus infection.The immunogenicity and safety of GSK's recombinant hepatitis B vaccine in adults: a systematic review of 30 years of experience.DNA vaccine cocktail expressing genotype A and C HBV surface and consensus core antigens generates robust cytotoxic and antibody responses in mice and Rhesus macaques.HCC-Associated Single Nucleotide Variants and Deletions Identified Using Genome-Wide High Throughput Analysis of HBV.Role natural killer group 2D-ligand interactions in hepatitis B infection.Clinical patterns associated with the concurrent detection of anti-HBs and HBV DNA.Effects of vaccine-acquired polyclonal anti-HBs antibodies on the prevention of HBV infection of non-vaccine genotypes.Unsolved problems and future perspectives of hepatitis B virus vaccination.Do we need better hepatitis B vaccines?Determining the Actual Prevalence of Hepatitis B in Khyber Pakhtunkhwa-Pakistan: A Meta-Analysis.Long-term impact of infant immunization on hepatitis B prevalence: a systematic review and meta-analysis.Editorial

P2860

Q26765290-5430E134-A264-4860-BE94-D52080BC403D Q30382346-C7D8D0C8-5A24-4A1A-B93A-311B3CF09AFD Q33623694-1389462B-D8AE-4543-956A-2A29E6602A97 Q33780105-FFFE8608-B5AC-4613-8AFB-45C319061C92 Q35097179-3F5AC2E8-0272-42CD-B34C-2C507D7BCC3C Q37044324-FA1E7A61-CB72-48F6-8B9D-1B86EF6D029E Q37347740-844FDC24-36C9-46C5-A3A5-882FB87AEB71 Q38098583-061F88E6-0427-4337-BE2F-013D88CECF32 Q38252962-23BE1F5A-31D7-4296-B507-99EB486CADED Q38675773-F67E2237-8725-466F-A587-50FBC8C28E37 Q39047929-E0FF3029-B9F8-4B7F-ADF8-2E3094F7F351 Q39428108-70D94439-1E5B-489E-8148-B00A0D6773C2 Q39995705-F66D784C-BAB8-454F-BD65-D39FBF86E936 Q40047815-329D3EAE-564F-4984-8ACE-01FE5D4C9BF0 Q40333038-4B6805EF-C48D-462A-A9F1-B79C51F8D760 Q42412334-DC8765B6-4901-432C-A0AC-56149DD0A69F Q46620323-8D36DC0E-9394-4AB1-9A50-E7A63E1320DC Q53835123-852D7263-8DEF-4286-85AA-FA425ED77E92 Q55405993-A6D83ADD-DEDE-44E0-8ADA-DA0A8BF79A18 Q57930358-63D6817F-6DC2-4C20-80B5-3A9C4318E677

P2860

Hepatitis B vaccine effectiveness in the face of global HBV genotype diversity.

http://www.wikidata.org/entity/Q37956379

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Hepatitis B vaccine effectiveness in the face of global HBV genotype diversity.

@en

Hepatitis B vaccine effectiveness in the face of global HBV genotype diversity.

@nl

type

label

Hepatitis B vaccine effectiveness in the face of global HBV genotype diversity.

@en

Hepatitis B vaccine effectiveness in the face of global HBV genotype diversity.

@nl

prefLabel

Hepatitis B vaccine effectiveness in the face of global HBV genotype diversity.

@en

Hepatitis B vaccine effectiveness in the face of global HBV genotype diversity.

@nl

P1433

Q37956379-E75F990E-47B1-4C9F-9FE0-B909FE446CB7

P1476

Q37956379-EDA11C8D-9921-4EC3-B717-4CF65554D04B

P2093

Q37956379-881505F4-D8CD-453E-9AD5-348A576C340A

Q37956379-C9E4F173-B42D-480A-A2BD-9042ED632029

Q37956379-E8E3A7BC-E6E8-4728-9A4C-F32FF4548A54

Q37956379-FDCD46A7-80CD-4995-A1B5-AB6BD0460E28

P2860

Q37956379-02114970-177E-44A5-86FF-A2810A0E2548

Q37956379-05B1DC5D-9FC1-4A8B-AACC-E341BAC325D9

Q37956379-061FB62A-4D87-4C12-9160-9D6F90DC1806

Q37956379-0BF012E1-5E7D-4602-B393-A636F7103E1D

Q37956379-0C19DA68-9C61-4DBD-90A4-E08FE4136BB4

Q37956379-12CC8122-F760-418E-9563-41D803A384A9

Q37956379-16126D1C-8C8A-49F2-ADE6-95289419AA53

Q37956379-1B6B96C4-5128-42EC-8014-83E2EB17D54A

Q37956379-23DCD7F1-25C1-4165-B48B-5570575F38BF

Q37956379-28870A65-B2E2-477D-B1A1-1E84E591ADBC

P304

Q37956379-2B176E05-B437-452C-9904-490911F701AD

P31

Q37956379-77D17E83-94B9-4D7C-BDA7-891D041A2044

P356

Q37956379-BC773702-E9DB-4441-AA9B-2BA486AEFB13

P433

Q37956379-3D63EE72-9A2E-4C12-9F79-188E6B764ECA

P478

Q37956379-34741867-2FE4-4FB8-8CB8-7A6546DC02B6

P50

Q37956379-37332729-4705-43D2-884D-F1F2373375F3

P577

Q37956379-3DCBDF88-AD4C-4EAD-81F0-575613279FD2

P5875

Q37956379-92F16B5A-CB11-4FFF-A336-59BE78628C93

P698

Q37956379-71D4D52C-38E4-4682-9C38-4331F4BADABC

P356

P1433

Expert Review of Vaccines

P1476

Hepatitis B vaccine effectiveness in the face of global HBV genotype diversity.

@en

P2093

Adrian Cassidy

http://www.w3.org/2001/XMLSchema#string

Antonio Olivieri

http://www.w3.org/2001/XMLSchema#string

Marc De Ridder

http://www.w3.org/2001/XMLSchema#string

Sally Mossman

http://www.w3.org/2001/XMLSchema#string

P2860

A genetic variant of hepatitis B virus divergent from known human and ape genotypes isolated from a Japanese patient and provisionally assigned to new genotype J

Molecular and phylogenetic analyses suggest an additional hepatitis B virus genotype "I".

Accumulation of substrates of the anaphase-promoting complex (APC) during human cytomegalovirus infection is associated with the phosphorylation of Cdh1 and the dissociation and relocalization of APC subunits.

Geographical and genetic diversity of the human hepatitis B virus.

Comprehensive control (or elimination) of hepatitis B virus transmission in the United States

Diagnostic strategy for occult hepatitis B virus infection.

Evidence of protection against clinical and chronic hepatitis B infection 20 years after infant vaccination in a high endemicity region

New immunization initiatives and progress toward the global control of hepatitis B.

Legend of hepatitis B vaccination: the Taiwan experience.

Relationship of genotypes of hepatitis B virus to mutations, disease progression and response to antiviral therapy.

P304

1709-1715

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1586/ERV.11.151

http://www.w3.org/2001/XMLSchema#string

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

10

http://www.w3.org/2001/XMLSchema#string

P50

Geert Leroux-Roels

P577

2011-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51800920

http://www.w3.org/2001/XMLSchema#string

P698

22085174

http://www.w3.org/2001/XMLSchema#string